GW-1100
|
GW 1100
|
306974-70-9
|
PH-064
|
892546-37-1
|
892546-37-1
|
ML216
|
N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲
|
1430213-30-1
|
Entasobulin
|
501921-61-5
|
501921-61-5
|
Boc-Dap-NE
|
BOC-DAP-NE
|
160800-65-7
|
Roblitinib (FGF401)
|
8-二氮雜萘-1(2H)-甲酰胺
|
1708971-55-4
|
Orelabrutinib
|
奧布替尼
|
1655504-04-3
|
ML-162
|
ML162
|
1035072-16-2
|
LEM-14
|
化合物 T9006
|
1814881-70-3
|
MSBN
|
MSBN
|
135980-66-4
|
DL5H3
|
1-Piperidinepropanamide, N-[1,2,3,9-tetrahydro-9-oxo-3-(phenylmethylene)pyrrolo[2,1-b]quinazolin-6-yl]-
|
90263-34-6
|
Nicomol
|
尼可莫爾
|
27959-26-8
|
Dronedarone
|
決奈達(dá)隆
|
141626-36-0
|
GRA Ex-25
|
N-[4-[[[反式-4-(1,1-二甲基乙基)環(huán)己基][[[4-(三氟甲氧基)苯基]氨基]羰基]氨基]甲基]芐基]-B-丙氨酸
|
307983-31-9
|
CCT241736
|
CS-2683
|
1402709-93-6
|
TIC10 (ONC201)
|
ONC201
|
1616632-77-9
|
BI-847325
|
BI-847325
|
1207293-36-4
|
PF-05221304
|
化合物PF-05221304
|
1370448-25-1
|
SYP-5
|
1384268-04-5
|
1384268-04-5
|
Batefenterol
|
BATEFENTEROL
|
743461-65-6
|
FB23
|
FB23
|
2243736-35-6
|
Treosulfan
|
曲奧舒凡
|
299-75-2
|
AZ 10606120 dihydrochloride
|
N-[2-[[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]-5-QUINOLINYL]-2-TRICYCLO[3.3.1.13,7]DEC-1-YLACETAMIDE DIHYDROCHLORIDE
|
607378-18-7
|
AEM1
|
AEM1
|
1030123-90-0
|
ARN272
|
ARN272
|
488793-85-7
|
GSK2200150A
|
1443138-53-1
|
1443138-53-1
|
TVB-3166
|
TVB-3166
|
1533438-83-3
|
BAY-293
|
(R)-6,7-二甲氧基-2-甲基-N-(1-(4-(2-((甲基氨基)甲基)苯基)噻吩-2-基)乙基)喹唑啉-4-胺
|
2244904-70-7
|
TH 5487
|
TH 5487
|
2304947-71-3
|
SKF38393 HCL
|
SKF38393 HCL
|
62717-42-4
|
PIM1/AKK1-IN-1
|
N-[5-(4-氰基苯基)-1H-吡咯并[2,3-B]吡啶-3-基]-3-吡啶甲酰胺
|
1093222-27-5
|
GLPG0634 analogue
|
GLPG0634
|
1206101-20-3
|
BAR501
|
CPDD0945
|
1632118-69-4
|
T 5601640
|
T5601640
|
924473-59-6
|
Ciforadenant (CPI-444)
|
CPI-444
|
1202402-40-1
|
LY2795050
|
LY2795050
|
1346133-08-1
|
GSK2981278
|
GSK2981278
|
1474110-21-8
|
Elafibranor
|
GFT505
|
923978-27-2
|
TM5007
|
化合物TM5007
|
342595-05-5
|
JNJ-63533054
|
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺
|
1802326-66-4
|
FF-10101
|
FF-10101
|
1472797-69-5
|
Eliprodil
|
依利羅地
|
119431-25-3
|
TSPC
|
TSPC
|
882286-32-0
|
MS4078
|
MS4078
|
2229036-62-6
|
JTE-013
|
JTE-013
|
383150-41-2
|
TAK-632
|
TAK-632
|
1228591-30-7
|
AZD-5069
|
AZD5069
|
878385-84-3
|
Seltorexant
|
JNJ-42847922
|
1293281-49-8
|
8-Bromo-cAMP sodium salt
|
8-溴腺苷-3',5'-環(huán)單磷酸鈉
|
76939-46-3
|
(-)-Dizocilpine
|
(-)-MK801MALEATE
|
121917-57-5
|
R243
|
R243
|
688352-84-3
|
SKLB-23bb
|
SKLB-23bb
|
1815580-06-3
|
GATA4-NKX2-5-IN-1
|
化合物GATA4-NKX2-5-IN-1
|
544681-96-1
|
Fmoc-3VVD-OH
|
FMOC-3AA-OH
|
863971-44-2
|
PD-089828
|
PD089828
|
179343-17-0
|
AZD2098
|
AZD2098
|
566203-88-1
|
GSK-114
|
GSK-114
|
1301761-96-5
|
Mc-Val-Ala-PAB
|
Mc-Val-Ala-PAB
|
1870916-87-2
|
NDI-091143
|
NDI-091143
|
2375840-87-0
|
ML397
|
4-[3-[2-[[4-(乙酰氨基)苯基]硫代]乙酰]-2,5-二甲基-1H-吡咯-1-基]苯甲酸甲酯
|
731006-86-3
|
GW9508
|
885101-89-3(GW9508)
|
885101-89-3
|
Cinacalcethydrochloride
|
鹽酸甲狀旁腺激素
|
364782-34-3
|
Maraviroc
|
馬拉維若
|
376348-65-1
|
AMD-070
|
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氫喹啉-8-基)丁烷-1,4-二胺
|
558447-26-0
|
BQ-123 SODIUM SALT
|
環(huán)(D-ALPHA-天冬氨酰-L-脯氨酰-D-纈氨酰-L-亮氨酰-D-色氨酰)
|
136553-81-6
|
TAK-779
|
TAK 799 ;TAK 779
|
229005-80-5
|
GANT 61
|
2,2'-[[二氫-2-(4-吡啶基)-1,3(2H,4H)-嘧啶二基]二(亞甲基)]二[N,N-二甲基苯胺]
|
500579-04-4
|
Vortioxetine(LuAA21004)HBr
|
氫溴酸沃替西汀
|
960203-27-4
|
BNC105
|
BNC105
|
945771-74-4
|
Fmoc-Phe-Lys(Trt)-PAB-PNP
|
FMOC-PHE-LYS(TRT)-PAB-PNP
|
1116086-09-9
|
Voxelotor (GBT440)
|
沃塞洛托
|
1446321-46-5
|
ARN14974
|
ARN14974
|
1644158-57-5
|
5WKS
|
化合物5WKS
|
1350752-07-6
|
CYM2503
|
(9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氫喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 環(huán)己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯
|
1308833-36-4
|
PZ-2891
|
PZ-2891
|
2170608-82-7
|
JNJ-7777120
|
JNJ7777120
|
459168-41-3
|
ML417
|
ML417
|
1386162-69-1
|
Simetride
|
西美曲特
|
154-82-5
|
Conivaptan hydrochloride
|
鹽酸考尼伐坦
|
168626-94-6
|
OC000459
|
[5-氟-2-甲基-3-(喹啉-2-基甲基)吲哚-1-基]乙酸
|
851723-84-7
|
BAY 57-1293
|
普瑞利韋
|
348086-71-5
|
Tazemetostat (EPZ-6438)
|
EPZ-6438
|
1403254-99-8
|
PF-3450074
|
PF-3450074
|
1352879-65-2
|
Matrine
|
苦參堿
|
519-02-8
|
GSK2256098
|
GSK-2256098
|
1224887-10-8
|
LOUREIRIN B
|
龍血素B
|
119425-90-0
|
FDL-169
|
FDL169
|
1628416-28-3
|
Maytansine
|
美坦新
|
35846-53-8
|
VUF 10166
|
VUF 10166
|
155584-74-0
|
TAE-1
|
2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide
|
1414469-59-2
|
LY2828360
|
CS-2878
|
1231220-79-3
|
MCHR1 antagonist 2
|
863115-70-2
|
863115-70-2
|
UBCS039
|
UBCS039
|
358721-70-7
|
TH-257
|
TH-257
|
2244678-29-1
|
WUN-29654
|
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy-
|
2407829-65-4
|
BAY 59-3074
|
BAY 59-3074
|
406205-74-1
|
NCGC 607
|
NCGC607
|
1462267-07-7
|
imidazenil
|
米達(dá)西尼
|
151271-08-8
|
PEO-IAA
|
2-(1H-吲哚-3-基)-4-氧基-4-苯基亮氨酸
|
6266-66-6
|
VU6015929
|
Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]-
|
2442597-56-8
|